查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1574053

居家医疗的全球市场:2024-2034年

Home Healthcare Market Report 2024-2034
出版日期: | 出版商: Visiongain | 英文 370 Pages | 商品交期: 最快1-2个工作天内

价格

预计到 2034 年，全球家庭医疗保健市场规模将以 9.2% 的复合年增长率成长。

科技的进步和对居家照护选择的认识的提高推动了显着的成长

技术进步正在显着推动家庭医疗保健市场的成长，特别是透过远距医疗和远端患者监控等创新。这些技术使医疗保健提供者能够远端管理患者，从而实现即时干预，从而改善结果并降低医疗成本。智慧感测器、远距医疗平台和医疗设备等远端监控解决方案正在推动全球对家庭医疗保健服务的需求，因为它们为传统护理提供了更方便、更有效率的替代方案。

此外，人们对家庭护理选择的认识不断提高，可支配收入不断增加，正在加速家庭护理的采用，特别是在老年人和卧床不起的患者中。与传统住院护理相比，这些服务不仅减少了再入院率，还提高了康復率。公司现在将重点放在印度和中国等新兴市场，以抓住这一不断增长的需求。

家庭医疗保健市场继续以服务业为主，预计到 2024 年将占收入占有率超过 60%。这一类别是根据是否有专门技能来划分的。熟练服务由持有执照的医疗保健专业人员提供，而非熟练服务提供非医疗支持，例如基本帮助和个人护理，以帮助患者在家中日常生活。医院费用的上涨预计将进一步增加对熟练护理服务的需求。

熟练护理服务涉及医疗专业人员，例如医生、註册护士、物理治疗师和专业护理人员，他们在家庭环境或专用护理机构中提供基本护理。随着患有糖尿病和心血管疾病等慢性病的老年人数量增加，对药物管理和持续监测等基本医疗服务的需求不断增加。由于医疗技术的进步，许多治疗现在可以在家中进行，为患者提供了更舒适、更方便的护理环境。这极大地促进了更广泛的家庭健康市场中熟练家庭护理服务的成长。

本报告提供全球居家医疗的市场调查，彙整市场概要，影响市场成长因素及市场机会分析，市场规模的转变·预测，各种区分·地区/各主要国家的详细分析，竞争情形，主要企业简介等资讯。

目录

第1章 报告概要

第2章 摘要整理

第3章 市场概要

  • 主要调查结果
  • 影响分析
  • 市场推动要素
    • 对经济高效且以患者为中心的医疗保健解决方案的需求不断增加
    • 远距医疗和远端监控设备的技术进步
    • 需要持续居家照护的慢性疾病增加
    • 寻求居家照护的长者数量增加
    • 政府促进家庭医疗保健服务的支持措施
  • 阻碍市场要素
    • 有关家庭医疗保健服务报销政策的问题
    • 影响居家照护产品核准和使用的监管障碍
    • 病人对居家医疗保健解决方案的认知与接受程度
  • 市场机会
    • 扩展数位医疗解决方案以增强远距患者管理
    • 扩大医疗保健提供者与科技公司之间的合作关係
    • 对预防保健和健康计划的兴趣日益浓厚
  • 新兴市场与大趋势
  • 波特的五力分析
  • PEST分析

第4章 居家医疗市场分析:各类型

  • 主要调查结果
  • 市场魅力指数
  • 市场规模的转变·预测
  • 产品
  • 服务
    • 市场规模的转变·预测:各地区
    • 市场占有率:各地区

第5章 居家医疗市场分析:各适应症

  • 主要调查结果
  • 市场魅力指数
  • 市场规模的转变·预测
  • 心血管疾病·高血压
  • 糖尿病·肾臟疾病
  • 神经疾病·精神疾病
  • 呼吸疾病·COPD
  • 母体的异常
  • 异动症
  • 癌症
  • 创伤护理
  • 其他
    • 市场规模的转变·预测:各地区
    • 市场占有率:各地区

第6章 居家医疗市场分析:各地区

  • 主要调查结果
  • 市场规模的转变·预测

第7章 北美的居家医疗市场分析

第8章 欧洲的居家医疗市场分析

第9章 亚太地区的居家医疗市场分析

第10章 南美的居家医疗市场分析

第11章 中东·非洲的居家医疗市场分析

第12章 企业简介

  • Abbott
  • Amedisys
  • Owens &Minor, Inc.
  • B. Braun Medical Ltd.
  • Baxter
  • BAYADA Home Health Care
  • ResMed
  • Koninklijke Philips N.V.
  • Fisher &Paykel Healthcare Limited
  • Fresenius Medical Care AG
  • GE HealthCare
  • Johnson &Johnson Services, Inc.
  • OMRON Corporation
  • McKesson Medical-Surgical Inc.
  • Medline
  • Medtronic
  • 3M Health Care
  • ARKRAY, Inc.
  • BD
  • Invacare Corporation
  • Hollister Incorporated
  • Convatec Group PLC
  • Molnlycke AB

第13章 总论·建议

  • Visiongain的总论
  • 市场参与企业的建议
Product Code: PHA1359

The global Home Healthcare market is projected to grow at a CAGR of 9.2% by 2034

The Home Healthcare Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Advancements in Technology and Rising Awareness of Home Care Options are Driving Significant Growth

Technological advancements are significantly driving the growth of the home healthcare market, particularly through innovations like telemedicine and remote patient monitoring. These technologies allow healthcare providers to manage patients remotely, enabling real-time interventions that improve outcomes and lower healthcare costs. Remote monitoring solutions, including smart sensors, telehealth platforms, and medical devices, are boosting global demand for home healthcare services as they offer more convenient and efficient alternatives to traditional care.

Additionally, rising awareness of home care options, coupled with growing disposable incomes, is accelerating the adoption of home healthcare, especially among elderly or bedridden patients. These services not only reduce hospital readmissions but also improve recovery rates compared to conventional inpatient care. Companies are now focusing on emerging markets, such as India and China, to capture this growing demand.

Segment Analysis

The services segment continues to dominate the home healthcare market, anticipated to capture a significant revenue share of over 60% in 2024. This segment is divided into skilled and unskilled home healthcare services. Skilled services are delivered by licensed healthcare professionals, while unskilled services provide non-medical support, such as basic assistance or personal care services, helping home-bound patients with daily living tasks. The rising costs of hospital admissions are expected to drive further demand for skilled care services.

Skilled nursing services involve healthcare professionals, such as physicians, registered nurses, physiotherapists, and specialized caregivers, offering critical care in home settings or dedicated care facilities. With a growing elderly population suffering from chronic conditions like diabetes and cardiovascular diseases, there is an increasing need for essential medical services, including medication management and continuous monitoring. Advancements in medical technology now enable many treatments to be administered at home, providing patients with a more comfortable and convenient care environment. This is significantly fueling the growth of skilled home care services within the broader home healthcare market.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the home healthcare market evolving?
  • What is driving and restraining the home healthcare market?
  • How will each home healthcare submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each home healthcare submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading home healthcare markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the home healthcare projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of
  • home healthcare projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the home healthcare market?
  • Where is the home healthcare market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the home healthcare market today, and over the next 10 years:

  • Our 370-page report provides 122 tables and 158 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
  • Forecasts to 2034 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces
  • Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

  • Type
  • Product
  • Diagnostic: Blood Glucose Monitors, Pulse Oximeters, Blood Pressure Monitors, Others
  • Treatment: Home Dialysis Machine, Infusion Pumps, Nebulizers, Oxygen Concentrators, Wheelchairs & Scooters, Walking Aid Devices, Others
  • Services
  • Skilled Home Healthcare: Physician Primary Care, Nursing Care, Physical/Occupational/Speech Therapy, Nutritional Support & Infusion Therapy, Hospice & Palliative, Others
  • Unskilled Home Healthcare
  • Indication
  • Cardiovascular Disorder & Hypertension
  • Diabetes & Kidney Disorders
  • Neurological & Mental Disorders
  • Respiratory Disease & COPD
  • Maternal Disorders
  • Mobility Disorders
  • Cancer
  • Wound Care
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • MEA
  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles for some of the leading companies in the Home Healthcare Market, 2024 to 2034, with a focus on this segment of these companies' operations.

  • Leading companies and the potential for market growth
  • Abbott
  • Amedisys
  • Owens & Minor, Inc.
  • B. Braun Medical Ltd.
  • Baxter
  • BAYADA Home Health Care
  • Koninklijke Philips N.V.
  • Fisher & Paykel Healthcare Limited
  • Fresenius Medical Care AG
  • GE HealthCare
  • Johnson & Johnson Services, Inc.
  • OMRON Corporation
  • McKesson Medical-Surgical Inc.
  • Medline
  • Medtronic
  • 3M Health Care
  • ARKRAY, Inc.
  • BD
  • Invacare Corporation
  • Hollister Incorporated
  • Convatec Group PLC
  • Molnlycke AB

Overall world revenue for Home Healthcare Market, 2024 to 2034 in terms of value the market will surpass US$400 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

  • How will the Home Healthcare Market, 2024 to 2034 report help you?
  • In summary, our 370+ page report provides you with the following knowledge:
  • Revenue forecasts to 2034 for Home Healthcare Market 2024 to 2034, with forecasts for Type and Indication, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 20 key national markets - See forecasts for the Home Healthcare Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 23 of the major companies involved in the Home Healthcare Market, 2024 to 2034.
  • Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
  • Information found nowhere else
  • With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Home Healthcare Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Home Healthcare Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Impact Analysis
  • 3.3 Market Driving Factors
    • 3.3.1 Rising Demand for Cost-Effective and Patient-Centred Healthcare Solutions
    • 3.3.2 Technological Advancements in Telehealth and Remote Monitoring Devices
    • 3.3.3 Increasing Prevalence of Chronic Diseases Requiring Ongoing Home Care
    • 3.3.4 Growing Geriatric Population Preferring to Receive Care at Home
    • 3.3.5 Supportive Government Initiatives Promoting Home Healthcare Services
  • 3.4 Market Restraining Factors
    • 3.4.1 Challenges Related to Reimbursement Policies for Home Healthcare Services
    • 3.4.2 Regulatory Hurdles Impacting the Approval and Usage of Home Care Products
    • 3.4.3 Limited Awareness and Acceptance of Home Healthcare Solutions Among Patients
  • 3.5 Market Opportunities
    • 3.5.1 Expansion of Digital Health Solutions Enhancing Remote Patient Management
    • 3.5.2 Increasing Partnerships Between Healthcare Providers and Technology Companies
    • 3.5.3 Growing Interest in Preventive Healthcare and Wellness Programs
  • 3.6 Emerging Markets and Megatrends
  • 3.7 Porter's Five Forces Analysis
    • 3.7.1 Bargaining Power of Suppliers
    • 3.7.2 Bargaining Power of Buyers
    • 3.7.3 Competitive Rivalry
    • 3.7.4 Threat of Substitutes
    • 3.7.5 Threat of New Entrants
  • 3.8 PEST Analysis

4 Home Healthcare Market Analysis by Type

  • 4.1 Key Findings
  • 4.2 Type Segment: Market Attractiveness Index
  • 4.3 Home Healthcare Market Size Estimation and Forecast by Type
  • 4.4 Product
    • 4.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Services
    • 4.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)

5 Home Healthcare Market Analysis by Indication

  • 5.1 Key Findings
  • 5.2 Indication Segment: Market Attractiveness Index
  • 5.3 Home Healthcare Market Size Estimation and Forecast by Indication
  • 5.4 Cardiovascular Disorder & Hypertension
    • 5.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Diabetes & Kidney Disorders
    • 5.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Neurological & Mental Disorders
    • 5.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)
  • 5.7 Respiratory Disease & COPD
    • 5.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.7.2 Market Share by Region, 2024 & 2034 (%)
  • 5.8 Maternal Disorders
    • 5.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.8.2 Market Share by Region, 2024 & 2034 (%)
  • 5.9 Mobility Disorders
    • 5.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.9.2 Market Share by Region, 2024 & 2034 (%)
  • 5.10 Cancer
    • 5.10.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.10.2 Market Share by Region, 2024 & 2034 (%)
  • 5.11 Wound Care
    • 5.11.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.11.2 Market Share by Region, 2024 & 2034 (%)
  • 5.12 Others
    • 5.12.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.12.2 Market Share by Region, 2024 & 2034 (%)

6 Home Healthcare Market Analysis by Region

  • 6.1 Key Findings
  • 6.2 Regional Market Size Estimation and Forecast

7 North America Home Healthcare Market Analysis

  • 7.1 Key Findings
  • 7.2 North America Home Healthcare Market Attractiveness Index
  • 7.3 North America Home Healthcare Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 7.4 North America Home Healthcare Market Size Estimation and Forecast by Country
  • 7.5 North America Home Healthcare Market Size Estimation and Forecast by Type
  • 7.6 North America Home Healthcare Market Size Estimation and Forecast by Indication
  • 7.7 U.S. Home Healthcare Market Analysis
  • 7.8 Canada Home Healthcare Market Analysis

8 Europe Home Healthcare Market Analysis

  • 8.1 Key Findings
  • 8.2 Europe Home Healthcare Market Attractiveness Index
  • 8.3 Europe Home Healthcare Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 8.4 Europe Home Healthcare Market Size Estimation and Forecast by Country
  • 8.5 Europe Home Healthcare Market Size Estimation and Forecast by Type
  • 8.6 Europe Home Healthcare Market Size Estimation and Forecast by Indication
  • 8.7 Germany Home Healthcare Market Analysis
  • 8.8 UK Home Healthcare Market Analysis
  • 8.9 France Home Healthcare Market Analysis
  • 8.10 Italy Home Healthcare Market Analysis
  • 8.11 Spain Home Healthcare Market Analysis
  • 8.12 Russia Home Healthcare Market Analysis
  • 8.13 Rest of Europe Home Healthcare Market Analysis

9 Asia Pacific Home Healthcare Market Analysis

  • 9.1 Key Findings
  • 9.2 Asia Pacific Home Healthcare Market Attractiveness Index
  • 9.3 Asia Pacific Home Healthcare Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 9.4 Asia Pacific Home Healthcare Market Size Estimation and Forecast by Country
  • 9.5 Asia Pacific Home Healthcare Market Size Estimation and Forecast by Type
  • 9.6 Asia Pacific Home Healthcare Market Size Estimation and Forecast by Indication
  • 9.7 Japan Home Healthcare Market Analysis
  • 9.8 China Home Healthcare Market Analysis
  • 9.9 India Home Healthcare Market Analysis
  • 9.10 Australia Home Healthcare Market Analysis
  • 9.11 South Korea Home Healthcare Market Analysis
  • 9.12 Rest of Asia Pacific Home Healthcare Market Analysis

10 Latin America Home Healthcare Market Analysis

  • 10.1 Key Findings
  • 10.2 Latin America Home Healthcare Market Attractiveness Index
  • 10.3 Latin America Home Healthcare Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 10.4 Latin America Home Healthcare Market Size Estimation and Forecast by Country
  • 10.5 Latin America Home Healthcare Market Size Estimation and Forecast by Type
  • 10.6 Latin America Home Healthcare Market Size Estimation and Forecast by Indication
  • 10.7 Brazil Home Healthcare Market Analysis
  • 10.8 Mexico Home Healthcare Market Analysis
  • 10.9 Argentina Home Healthcare Market Analysis
  • 10.10 Colombia Home Healthcare Market Analysis
  • 10.11 Rest of Latin America Home Healthcare Market Analysis

11 MEA Home Healthcare Market Analysis

  • 11.1 Key Findings
  • 11.2 MEA Home Healthcare Market Attractiveness Index
  • 11.3 MEA Home Healthcare Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 11.4 MEA Home Healthcare Market Size Estimation and Forecast by Country
  • 11.5 MEA Home Healthcare Market Size Estimation and Forecast by Type
  • 11.6 MEA Home Healthcare Market Size Estimation and Forecast by Indication
  • 11.7 GCC Home Healthcare Market Analysis
  • 11.8 South Africa Home Healthcare Market Analysis
  • 11.9 Rest of MEA Home Healthcare Market Analysis

12 Company Profiles

  • 12.1 Abbott
    • 12.1.1 Company Snapshot
    • 12.1.2 Company Overview
    • 12.1.3 Company Financials
      • 12.1.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.1.3.2 R&D, 2021-2023 (US$ Million)
      • 12.1.3.3 Regional Shares, 2023 (%)
      • 12.1.3.4 Business Segment Market Shares, 2023 (%)
    • 12.1.4 Product Benchmarking
    • 12.1.5 Strategic Outlook
  • 12.2 Amedisys
    • 12.2.1 Company Snapshot
    • 12.2.2 Company Overview
    • 12.2.3 Company Financials
      • 12.2.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.2.3.2 R&D, 2021-2023 (US$ Million)
      • 12.2.3.3 Regional Shares, 2023 (%)
      • 12.2.3.4 Business Segment Market Shares, 2023 (%)
    • 12.2.4 Product Benchmarking
    • 12.2.5 Strategic Outlook
  • 12.3 Owens & Minor, Inc.
    • 12.3.1 Company Snapshot
    • 12.3.2 Company Overview
    • 12.3.3 Company Financials
      • 12.3.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.3.3.2 R&D, 2021-2023 (US$ Million)
      • 12.3.3.3 Regional Shares, 2023 (%)
      • 12.3.3.4 Business Segment Market Shares, 2023 (%)
    • 12.3.4 Product Benchmarking
    • 12.3.5 Strategic Outlook
  • 12.4 B. Braun Medical Ltd.
    • 12.4.1 Company Snapshot
    • 12.4.2 Company Overview
    • 12.4.3 Company Financials
      • 12.4.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.4.3.2 R&D, 2021-2023 (US$ Million)
      • 12.4.3.3 Regional Shares, 2023 (%)
      • 12.4.3.4 Business Segment Market Shares, 2023 (%)
    • 12.4.4 Product Benchmarking
    • 12.4.5 Strategic Outlook
  • 12.5 Baxter
    • 12.5.1 Company Snapshot
    • 12.5.2 Company Overview
    • 12.5.3 Company Financials
      • 12.5.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.5.3.2 R&D, 2021-2023 (US$ Million)
      • 12.5.3.3 Regional Shares, 2023 (%)
      • 12.5.3.4 Business Segment Market Shares, 2023 (%)
    • 12.5.4 Product Benchmarking
    • 12.5.5 Strategic Outlook
  • 12.6 BAYADA Home Health Care
    • 12.6.1 Company Snapshot
    • 12.6.2 Company Overview
    • 12.6.3 Company Financials
      • 12.6.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.6.3.2 R&D, 2021-2023 (US$ Million)
      • 12.6.3.3 Regional Shares, 2023 (%)
      • 12.6.3.4 Business Segment Market Shares, 2023 (%)
    • 12.6.4 Product Benchmarking
    • 12.6.5 Strategic Outlook
  • 12.7 ResMed
    • 12.7.1 Company Snapshot
    • 12.7.2 Company Overview
    • 12.7.3 Company Financials
      • 12.7.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.7.3.2 R&D, 2021-2023 (US$ Million)
      • 12.7.3.3 Regional Shares, 2023 (%)
      • 12.7.3.4 Business Segment Market Shares, 2023 (%)
    • 12.7.4 Product Benchmarking
    • 12.7.5 Strategic Outlook
  • 12.8 Koninklijke Philips N.V.
    • 12.8.1 Company Snapshot
    • 12.8.2 Company Overview
    • 12.8.3 Company Financials
      • 12.8.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.8.3.2 R&D, 2021-2023 (US$ Million)
      • 12.8.3.3 Regional Shares, 2023 (%)
      • 12.8.3.4 Business Segment Market Shares, 2023 (%)
    • 12.8.4 Product Benchmarking
    • 12.8.5 Strategic Outlook
  • 12.9 Fisher & Paykel Healthcare Limited
    • 12.9.1 Company Snapshot
    • 12.9.2 Company Overview
    • 12.9.3 Company Financials
      • 12.9.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.9.3.2 R&D, 2021-2023 (US$ Million)
      • 12.9.3.3 Regional Shares, 2023 (%)
      • 12.9.3.4 Business Segment Market Shares, 2023 (%)
    • 12.9.4 Product Benchmarking
    • 12.9.5 Strategic Outlook
  • 12.10 Fresenius Medical Care AG
    • 12.10.1 Company Snapshot
    • 12.10.2 Company Overview
    • 12.10.3 Company Financials
      • 12.10.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.10.3.2 R&D, 2021-2023 (US$ Million)
      • 12.10.3.3 Regional Shares, 2023 (%)
      • 12.10.3.4 Business Segment Market Shares, 2023 (%)
    • 12.10.4 Product Benchmarking
    • 12.10.5 Strategic Outlook
  • 12.11 GE HealthCare
    • 12.11.1 Company Snapshot
    • 12.11.2 Company Overview
    • 12.11.3 Company Financials
      • 12.11.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.11.3.2 R&D, 2021-2023 (US$ Million)
      • 12.11.3.3 Regional Shares, 2023 (%)
      • 12.11.3.4 Business Segment Market Shares, 2023 (%)
    • 12.11.4 Product Benchmarking
    • 12.11.5 Strategic Outlook
  • 12.12 Johnson & Johnson Services, Inc.
    • 12.12.1 Company Snapshot
    • 12.12.2 Company Overview
    • 12.12.3 Company Financials
      • 12.12.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.12.3.2 R&D, 2021-2023 (US$ Million)
      • 12.12.3.3 Regional Shares, 2023 (%)
      • 12.12.3.4 Business Segment Market Shares, 2023 (%)
    • 12.12.4 Product Benchmarking
    • 12.12.5 Strategic Outlook
  • 12.13 OMRON Corporation
    • 12.13.1 Company Snapshot
    • 12.13.2 Company Overview
    • 12.13.3 Company Financials
      • 12.13.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.13.3.2 R&D, 2021-2023 (US$ Million)
      • 12.13.3.3 Regional Shares, 2023 (%)
      • 12.13.3.4 Business Segment Market Shares, 2023 (%)
    • 12.13.4 Product Benchmarking
    • 12.13.5 Strategic Outlook
  • 12.14 McKesson Medical-Surgical Inc.
    • 12.14.1 Company Snapshot
    • 12.14.2 Company Overview
    • 12.14.3 Company Financials
      • 12.14.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.14.3.2 R&D, 2021-2023 (US$ Million)
      • 12.14.3.3 Regional Shares, 2023 (%)
      • 12.14.3.4 Business Segment Market Shares, 2023 (%)
    • 12.14.4 Product Benchmarking
    • 12.14.5 Strategic Outlook
  • 12.15 Medline
    • 12.15.1 Company Snapshot
    • 12.15.2 Company Overview
    • 12.15.3 Company Financials
      • 12.15.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.15.3.2 R&D, 2021-2023 (US$ Million)
      • 12.15.3.3 Regional Shares, 2023 (%)
      • 12.15.3.4 Business Segment Market Shares, 2023 (%)
    • 12.15.4 Product Benchmarking
    • 12.15.5 Strategic Outlook
  • 12.16 Medtronic
    • 12.16.1 Company Snapshot
    • 12.16.2 Company Overview
    • 12.16.3 Company Financials
      • 12.16.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.16.3.2 R&D, 2021-2023 (US$ Million)
      • 12.16.3.3 Regional Shares, 2023 (%)
      • 12.16.3.4 Business Segment Market Shares, 2023 (%)
    • 12.16.4 Product Benchmarking
    • 12.16.5 Strategic Outlook
  • 12.17 3M Health Care
    • 12.17.1 Company Snapshot
    • 12.17.2 Company Overview
    • 12.17.3 Company Financials
      • 12.17.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.17.3.2 R&D, 2021-2023 (US$ Million)
      • 12.17.3.3 Regional Shares, 2023 (%)
      • 12.17.3.4 Business Segment Market Shares, 2023 (%)
    • 12.17.4 Product Benchmarking
    • 12.17.5 Strategic Outlook
  • 12.18 ARKRAY, Inc.
    • 12.18.1 Company Snapshot
    • 12.18.2 Company Overview
    • 12.18.3 Company Financials
      • 12.18.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.18.3.2 R&D, 2021-2023 (US$ Million)
      • 12.18.3.3 Regional Shares, 2023 (%)
      • 12.18.3.4 Business Segment Market Shares, 2023 (%)
    • 12.18.4 Product Benchmarking
    • 12.18.5 Strategic Outlook
  • 12.19 BD
    • 12.19.1 Company Snapshot
    • 12.19.2 Company Overview
    • 12.19.3 Company Financials
      • 12.19.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.19.3.2 R&D, 2021-2023 (US$ Million)
      • 12.19.3.3 Regional Shares, 2023 (%)
      • 12.19.3.4 Business Segment Market Shares, 2023 (%)
    • 12.19.4 Product Benchmarking
    • 12.19.5 Strategic Outlook
  • 12.20 Invacare Corporation
    • 12.20.1 Company Snapshot
    • 12.20.2 Company Overview
    • 12.20.3 Company Financials
      • 12.20.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.20.3.2 R&D, 2021-2023 (US$ Million)
      • 12.20.3.3 Regional Shares, 2023 (%)
      • 12.20.3.4 Business Segment Market Shares, 2023 (%)
    • 12.20.4 Product Benchmarking
    • 12.20.5 Strategic Outlook
  • 12.21 Hollister Incorporated
    • 12.21.1 Company Snapshot
    • 12.21.2 Company Overview
    • 12.21.3 Company Financials
      • 12.21.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.21.3.2 R&D, 2021-2023 (US$ Million)
      • 12.21.3.3 Regional Shares, 2023 (%)
      • 12.21.3.4 Business Segment Market Shares, 2023 (%)
    • 12.21.4 Product Benchmarking
    • 12.21.5 Strategic Outlook
  • 12.22 Convatec Group PLC
    • 12.22.1 Company Snapshot
    • 12.22.2 Company Overview
    • 12.22.3 Company Financials
      • 12.22.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.22.3.2 R&D, 2021-2023 (US$ Million)
      • 12.22.3.3 Regional Shares, 2023 (%)
      • 12.22.3.4 Business Segment Market Shares, 2023 (%)
    • 12.22.4 Product Benchmarking
    • 12.22.5 Strategic Outlook
  • 12.23 Molnlycke AB
    • 12.23.1 Company Snapshot
    • 12.23.2 Company Overview
    • 12.23.3 Company Financials
      • 12.23.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.23.3.2 R&D, 2021-2023 (US$ Million)
      • 12.23.3.3 Regional Shares, 2023 (%)
      • 12.23.3.4 Business Segment Market Shares, 2023 (%)
    • 12.23.4 Product Benchmarking
    • 12.23.5 Strategic Outlook

13 Conclusion and Recommendations

  • 13.1 Concluding Remarks from Visiongain
  • 13.2 Recommendations for Market Players

List of Tables

  • Table 1 Home Healthcare Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
  • Table 2 Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 3 Product Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 4 Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 5 Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 6 Cardiovascular Disorder & Hypertension Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 7 Diabetes & Kidney Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 8 Neurological & Mental Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 9 Respiratory Disease & COPD Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 10 Maternal Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 11 Mobility Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 12 Cancer Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 13 Wound Care Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 14 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 15 Home Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 16 North America Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 17 North America Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 18 North America Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 19 U.S. Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 20 Canada Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 21 Europe Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 22 Europe Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 23 Europe Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 24 Germany Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 25 UK Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 26 France Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 27 Italy Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 28 Spain Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 29 Russia Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 30 Rest of Europe Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 31 Asia Pacific Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 32 Asia Pacific Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 33 Asia Pacific Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 34 Japan Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 35 China Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 36 India Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 37 Australia Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 38 South Korea Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 39 Rest of Asia Pacific Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 40 Latin America Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 41 Latin America Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 42 Latin America Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 43 Brazil Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 44 Mexico Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 45 Argentina Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 46 Colombia Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 47 Rest of Latin America Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 48 MEA Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 49 MEA Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 50 MEA Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 51 GCC Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 52 South Africa Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 53 Rest of MEA Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 54 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 55 Abbott: Product Benchmarking
  • Table 56 Abbott: Strategic Outlook
  • Table 57 Amedisys, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 58 Amedisys, Inc.: Product Benchmarking
  • Table 59 Amedisys, Inc.: Strategic Outlook
  • Table 60 Owens & Minor, Inc. Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 61 Owens & Minor, Inc. Product Benchmarking
  • Table 62 Owens & Minor, Inc. Strategic Outlook
  • Table 63 B. Braun Medical Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 64 B. Braun Medical Ltd.: Product Benchmarking
  • Table 65 B. Braun Medical Ltd.: Strategic Outlook
  • Table 66 Baxter: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 67 Baxter: Product Benchmarking
  • Table 68 Baxter: Strategic Outlook
  • Table 69 BAYADA Home Health Care: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 70 BAYADA Home Health Care: Product Benchmarking
  • Table 71 BAYADA Home Health Care: Strategic Outlook
  • Table 72 ResMed: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 73 ResMed: Product Benchmarking
  • Table 74 ResMed: Strategic Outlook
  • Table 75 Koninklijke Philips N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 76 Koninklijke Philips N.V.: Product Benchmarking
  • Table 77 Koninklijke Philips N.V.: Strategic Outlook
  • Table 78 Fisher & Paykel Healthcare Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 79 Fisher & Paykel Healthcare Limited: Product Benchmarking
  • Table 80 Fisher & Paykel Healthcare Limited: Strategic Outlook
  • Table 81 Fresenius Medical Care AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 82 Fresenius Medical Care AG: Product Benchmarking
  • Table 83 Fresenius Medical Care AG: Strategic Outlook
  • Table 84 GE HealthCare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 GE HealthCare: Product Benchmarking
  • Table 86 GE HealthCare: Strategic Outlook
  • Table 87 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Johnson & Johnson Services, Inc.: Product Benchmarking
  • Table 89 Johnson & Johnson Services, Inc.: Strategic Outlook
  • Table 90 OMRON Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 OMRON Corporation: Product Benchmarking
  • Table 92 OMRON Corporation: Strategic Outlook
  • Table 93 McKesson Medical-Surgical Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 94 McKesson Medical-Surgical Inc.: Product Benchmarking
  • Table 95 McKesson Medical-Surgical Inc.: Strategic Outlook
  • Table 96 Medline: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 97 Medline: Product Benchmarking
  • Table 98 Medline: Strategic Outlook
  • Table 99 Medtronic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 100 Medtronic: Product Benchmarking
  • Table 101 Medtronic: Strategic Outlook
  • Table 102 3M Health Care: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 103 3M Health Care: Product Benchmarking
  • Table 104 3M Health Care: Strategic Outlook
  • Table 105 ARKRAY, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 106 ARKRAY, Inc.: Product Benchmarking
  • Table 107 ARKRAY, Inc.: Strategic Outlook
  • Table 108 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 BD: Product Benchmarking
  • Table 110 BD: Strategic Outlook
  • Table 111 Invacare Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 112 Invacare Corporation: Product Benchmarking
  • Table 113 Invacare Corporation: Strategic Outlook
  • Table 114 Hollister Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 115 Hollister Incorporated: Product Benchmarking
  • Table 116 Hollister Incorporated: Strategic Outlook
  • Table 117 Convatec Group PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 118 Convatec Group PLC: Product Benchmarking
  • Table 119 Convatec Group PLC: Strategic Outlook
  • Table 120 Molnlycke AB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 121 Molnlycke AB: Product Benchmarking
  • Table 122 Molnlycke AB: Strategic Outlook

List of Figures

  • Figure 1 Home Healthcare Market Segmentation
  • Figure 2 Home Healthcare Market by Type: Market Attractiveness Index
  • Figure 3 Home Healthcare Market by Indication: Market Attractiveness Index
  • Figure 4 Home Healthcare Market Attractiveness Index by Region
  • Figure 5 Home Healthcare Market: Market Dynamics
  • Figure 6 Home Healthcare Market: Porter's Five Forces Analysis
  • Figure 7 Home Healthcare Market: PEST Analysis
  • Figure 8 Home Healthcare Market Attractiveness Index by Type
  • Figure 9 Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 10 Home Healthcare Market Share Forecast by Type, 2024, 2029, 2034 (%)
  • Figure 11 Product Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 12 Product Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 13 Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 14 Services Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 15 Home Healthcare Market Attractiveness Index by Indication
  • Figure 16 Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %)
  • Figure 17 Home Healthcare Market Share Forecast by Indication, 2024, 2029, 2034 (%)
  • Figure 18 Cardiovascular Disorder & Hypertension Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 19 Cardiovascular Disorder & Hypertension Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 20 Diabetes & Kidney Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 21 Diabetes & Kidney Disorders Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 22 Neurological & Mental Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 23 Neurological & Mental Disorders Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 24 Respiratory Disease & COPD Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 25 Respiratory Disease & COPD Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 26 Maternal Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 27 Maternal Disorders Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 28 Mobility Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 29 Mobility Disorders Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 30 Cancer Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 31 Cancer Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 32 Wound Care Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 33 Wound Care Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 34 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 35 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 36 Home Healthcare Market Forecast by Region 2024, 2029, 2034 (Revenue, CAGR%)
  • Figure 37 Home Healthcare Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 38 Home Healthcare Market by Region, 2024-2034 (US$ Bn, AGR %)
  • Figure 39 North America Home Healthcare Market Attractiveness Index
  • Figure 40 North America Home Healthcare Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 41 North America Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 42 North America Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 43 North America Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %)
  • Figure 44 U.S. Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 45 Canada Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 46 Europe Home Healthcare Market Attractiveness Index
  • Figure 47 Europe Home Healthcare Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 48 Europe Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 49 Europe Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 50 Europe Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %)
  • Figure 51 Germany Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 52 UK Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 53 France Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 54 Italy Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 55 Spain Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 56 Russia Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 57 Rest of Europe Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 58 Asia Pacific Home Healthcare Market Attractiveness Index
  • Figure 59 Asia Pacific Home Healthcare Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 60 Asia Pacific Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 61 Asia Pacific Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 62 Asia Pacific Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %)
  • Figure 63 Japan Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 64 China Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 65 India Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 66 Australia Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 67 South Korea Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 68 Rest of Asia Pacific Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 69 Latin America Home Healthcare Market Attractiveness Index
  • Figure 70 Latin America Home Healthcare Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 71 Latin America Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 72 Latin America Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 73 Latin America Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %)
  • Figure 74 Brazil Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 75 Mexico Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 76 Argentina Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 77 Colombia Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 78 Rest of Latin America Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 79 MEA Home Healthcare Market Attractiveness Index
  • Figure 80 MEA Home Healthcare Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 81 MEA Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 82 MEA Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 83 MEA Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %)
  • Figure 84 GCC Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 85 South Africa Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 86 Rest of MEA Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 87 Abbott: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 88 Abbott: Regional Market Shares (%), 2023
  • Figure 89 Abbott: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 90 Abbott: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 91 Abbott: Regional Market Shares (%), 2023
  • Figure 92 Abbott: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 93 Amedisys, Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 94 Amedisys, Inc.: Regional Market Shares (%), 2023
  • Figure 95 Amedisys, Inc.: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 96 Owens & Minor, Inc. Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 97 Owens & Minor, Inc. Regional Market Shares (%), 2023
  • Figure 98 Owens & Minor, Inc. R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 99 B. Braun Medical Ltd.: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 100 B. Braun Medical Ltd.: Regional Market Shares (%), 2023
  • Figure 101 B. Braun Medical Ltd.: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 102 Baxter: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 103 Baxter: Regional Market Shares (%), 2023
  • Figure 104 Baxter: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 105 BAYADA Home Health Care: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 106 BAYADA Home Health Care: Regional Market Shares (%), 2023
  • Figure 107 BAYADA Home Health Care: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 108 ResMed: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 109 ResMed: Regional Market Shares (%), 2023
  • Figure 110 ResMed: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 111 Koninklijke Philips N.V.: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 112 Koninklijke Philips N.V.: Regional Market Shares (%), 2023
  • Figure 113 Koninklijke Philips N.V.: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 114 Fisher & Paykel Healthcare Limited: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 115 Fisher & Paykel Healthcare Limited: Regional Market Shares (%), 2023
  • Figure 116 Fisher & Paykel Healthcare Limited: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 117 Fresenius Medical Care AG: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 118 Fresenius Medical Care AG: Regional Market Shares (%), 2023
  • Figure 119 Fresenius Medical Care AG: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 120 GE HealthCare: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 121 GE HealthCare: Regional Market Shares (%), 2023
  • Figure 122 GE HealthCare: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 123 Johnson & Johnson Services, Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 124 Johnson & Johnson Services, Inc.: Regional Market Shares (%), 2023
  • Figure 125 Johnson & Johnson Services, Inc.: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 126 OMRON Corporation: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 127 OMRON Corporation: Regional Market Shares (%), 2023
  • Figure 128 OMRON Corporation: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 129 McKesson Medical-Surgical Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 130 McKesson Medical-Surgical Inc.: Regional Market Shares (%), 2023
  • Figure 131 McKesson Medical-Surgical Inc.: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 132 Medline: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 133 Medline: Regional Market Shares (%), 2023
  • Figure 134 Medline: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 135 Medtronic: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 136 Medtronic: Regional Market Shares (%), 2023
  • Figure 137 Medtronic: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 138 3M Health Care: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 139 3M Health Care: Regional Market Shares (%), 2023
  • Figure 140 3M Health Care: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 141 ARKRAY, Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 142 ARKRAY, Inc.: Regional Market Shares (%), 2023
  • Figure 143 ARKRAY, Inc.: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 144 BD: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 145 BD: Regional Market Shares (%), 2023
  • Figure 146 BD: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 147 Invacare Corporation: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 148 Invacare Corporation: Regional Market Shares (%), 2023
  • Figure 149 Invacare Corporation: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 150 Hollister Incorporated: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 151 Hollister Incorporated: Regional Market Shares (%), 2023
  • Figure 152 Hollister Incorporated: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 153 Convatec Group PLC: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 154 Convatec Group PLC: Regional Market Shares (%), 2023
  • Figure 155 Convatec Group PLC: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 156 Molnlycke AB: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 157 Molnlycke AB: Regional Market Shares (%), 2023
  • Figure 158 Molnlycke AB: R&D, 2021-2023 (US$ Million, AGR %)